We describe two Ebola virus (EBOV) RT-PCR discordant mother-child pairs. In the first, blood from the breastfeeding mother, recovering from EBOV infection, tested negative twice but her urine tested positive. Her child became infected by EBOV and died. In the second, the breastfed child remained EBOV-negative, although the mother's blood tested positive. We highlight possible benefits of EBOV RT-PCR testing in urine and breast milk and the need for hygiene counselling when those fluids are EBOV-positive.
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We report two Ebola virus (EBOV) RT-PCR discordant mother-child pairs that illustrate that EBOV RT-PCR testing of relevant fluids in addition to blood, such as urine and breast milk, may be useful, in certain instances.
Background
The current West African Ebola virus disease (EVD) epidemic is different from all previous EVD outbreaks [1] . Because of its regional and international distribution, the massive strain on the local health systems in the affected countries and the very large number of persons infected, the current outbreak has evolved into a major humanitarian crisis [2] .
Offering patient care to breastfeeding Ebola virus (EBOV) infected women and their children in such a setting can be particularly challenging because evidencebased guidelines about breastfeeding are lacking. This report of two EBOV RT-PCR discordant mother-child pairs illustrates possible benefits of EBOV RT-PCR testing in urine and breast milk, not just in blood.
Case 1: mother-child pair
In early October 2014, a woman in her late 30s was referred to the Ebola Treatment Centre (ETC) of Médecins Sans Frontières (MSF) in Guéckédou, Guinea because of general malaise and myalgia. She was accompanied by her asymptomatic, almost exclusively breastfed, six-month-old infant.
The patient had taken care of a relative who had developed symptoms compatible with EBOV in early September and had died 12 days after symptom onset. The patient had also organised the funeral. Two days after the relative's death, she developed high fever, intense fatigue, headache, muscle and abdominal pain, vomiting and diarrhoea. She was admitted to a local hospital where she received oral and intravenous empirical anti-malaria treatment and antibiotics for three days. The diagnosis was unclear. Although she had symptoms compatible with EBOV infection, she was not tested for EVD as EBOV RT-PCR tests were not available.
After three days in hospital, 13 days after the onset of her symptoms, the patient was referred to the ETC of MSF for persistent malaise and myalgia. Upon admission, she was afebrile. Given the clinical history and the high-risk contact, the patient was admitted to the ETC in the 'suspect' zone of the 'high-risk' area. Her asymptomatic child was housed in a nursery next to the ETC and breastfeeding was stopped. On day 14 of illness, the patient's EBOV RT-PCR blood test (Realstar Filovirus Screen, RT-PCR Kit 1.0, Altona Diagnostics, Hamburg) as well as a rapid malaria test (SD BIOLINE Malaria Ag P.f, Standard Diagnosics Inc.) were negative.
On the same day (day 14 of illness of the mother), the child developed fever (39.1 °C), diarrhoea and severe weakness; a malaria rapid test was negative but EBOV RT-PCR test was positive (cycle threshold (CT) value 19.80; CT values < 20 are highly positive whereas > 35 are weakly positive).
A second EBOV RT-PCR blood test of the mother, 16 days after symptom onset, remained negative but the urine EBOV RT-PCR test from the same day was positive (CT value 29.09). EBOV RT-PCR test of breast milk performed on day 17 after symptom onset was negative and breastfeeding was restarted. The patient had recovered well and was discharged on the same day but the child passed away three days later.
Case 2: mother-child pair
A woman in her mid-20s developed a febrile syndrome four days after having given birth to a healthy baby and was admitted to an MSF ETC in Guéckédou five days later. We note that a close relative of the patient who was present during the delivery, developed symptoms compatible with EVD on the day following the delivery and died one week later. The patient had taken care of this relative.
Upon admission, the patient's temperature was 39 °C and she had severe weakness, myalgia, arthralgia, anorexia, dysphagia, hiccups, abdominal pain and diarrhoea. Minor bloody vaginal discharge was noted. An oral antibiotic (cefixime) and anti-malaria treatment were started empirically. On day 6 after onset of illness, a rapid malaria test was negative but an EBOV RT-PCR blood test was positive (CT value 23.92). The clinical course of the patient was favourable and she was declared cured 12 days later (day 18 after onset of illness). After two negative EBOV RT-PCR blood tests, 24 hours apart, she was discharged from hospital. No EBOV RT-PCR of the breast milk was performed.
Upon admission, her infant was 10 days old and had been breastfed since birth. The child was immediately separated from the mother and breastfeeding was stopped. Six days later, the child developed fever (38.9 °C). Ceftriaxone and gentamicin were started. Artesunate was also given but stopped after a negative malaria test. EBOV RT-PCR blood tests were negative on day 1 and 3 after onset of fever. Gentamicin was stopped after two days but ceftriaxone continued for eight days with a favourable clinical outcome. The infant rapidly became asymptomatic and was followed up for 21 days after the last contact with the sick mother. The child did not develop EVD.
Discussion
We describe two EBOV RT-PCR discordant mother-child pairs that illustrate the complexity of taking care of patients with EBOV infection.
If a lactating mother's blood is EBOV RT-PCR negative and has an EBOV-positive breastfed child (Case 1), healthcare workers should investigate whether the mother recently recovered from a confirmed or suspected EBOV infection. The mother's urine and breast milk should be tested by EBOV RT-PCR for shedding of EBOV even after the virus becomes undetectable in the blood [3, 4] . The child in Case 1 described, was most likely infected by the mother, however, whether the child became infected through breast milk or through contact with another bodily fluid, remains unknown. We cannot fully rule out the possibility that the source of the child's infection was the relative who was taken care of by the child's mother but this would mean the incubation period of the child was at least 16 days which is long given the average incubation period of 8 to 10 days [5] .
Data on how long infective EBOV can be present in other body fluids such as saliva, tears, urine, stool, breast milk, vaginal and amniotic fluid and seminal fluids, are still limited [4] . We do know that in the 36-yearold patient with EVD who was evacuated in August 2014 to an isolation facility in Hamburg, Germany, infective EBOV was still isolated from urine samples on day 26 of his illness, nine days after the clearance of EBOV from plasma [3] . We also know that EBOV can be isolated from convalescent patients in semen up to 82 days after disease onset [6] . However, in a study by Bausch et al., EBOV could not be cultured from the urine in 11 cases, but this might have been caused by virus degradation from breaks in the cold chain during sample collection, storage and shipping [4] .
Detection for long periods of time in urine is known for other viruses, such as the West Nile virus [7] but poorly documented for EVD. The added value of EBOV testing of the urine of convalescent patients remains to be determined. Indeed, a positive PCR test does not mean the urine is still infectious and it would be impossible to keep patients with positive EBOV RT-PCR urine or semen tests for months in isolation.
EBOV has been detected in breast milk previously [4] but the timing of EBOV appearance, how long it remains in breast milk in an EBOV-infected lactating mother and the exact risk for a child to become infected through breastfeeding, remain poorly understood. EBOV was isolated from the breast milk of one lactating woman 15 days after disease onset, and after EBOV was already cleared from the blood [4] . We will need prospective studies of mother and child pairs, combining PCR testing with virus culture of breast milk to finally come up with evidence-based recommendations regarding breastfeeding in cases of lactating mothers with EVD. Although high levels of actively produced IgA in breast milk have been shown to provide limited local mucosal protection for breastfed children against influenza virus infection [8] , further studies are needed to determine the cellular and immunologic effects of breast milk-secreted antibodies in EVD patients.
These two cases demonstrate that when caring for mother-child pairs, healthcare workers should consider the potential role of testing relevant body fluids in addition to blood, such as urine and breast milk.
In case of discordant RT-PCR results between an EBOV-positive mother and her EBOV-negative breastfed child, ideally, breastfeeding should be stopped if safe replacement for breastfeeding is available [9] . Otherwise, feeding the child with heat-treated expressed breast milk [10] could be considered. Where a mother has survived EVD, ideally, her breast milk should be confirmed negative for EBOV before resuming breastfeeding. If EBOV RT-PCR diagnostic is not available, it is advised to avoid breastfeeding by EVDsurviving mothers [9] .
The possibility of prolonged EBOV shedding in urine and breast milk means that counselling about hygiene in handling those fluids should be an important component of health promotion at the time of discharge from the ETC.
